EFFECT OF GLP1 RECEPTOR AGONISTS IN PATIENTS ON SGLT2 INHIBITOR THERAPY As discussed earlier, the effect of a GLP-1 RA (efpeglenatide- not available) in patients on an SGLT-2 inhibitor was determined in the AMPLITUDE-O trial (312)
reported that blueberry anthocyanin extract inhibits ER stress, thereby providing relief for DR patients (363)
Also, the manufacturers of Qsymia and Contrave have coupons on their websites. Another helpful resource Corrado recommends is The Obesity Action Coalition, an education and advocacy organization with evidence-based resources and directories to help you find providers in your area
What this means for members Patients with IBX plans who are currently taking a GLP-1 or non-GLP-1 drug for weight loss and want to continue taking the medication will be responsible for the full cost of the drug beginning January 1, 2025, or when their coverage plan renews
Blum says there are three major factors to consider: those looking for weight maintenance, those who would like to tap into the anti-inflammatory benefits of GLP-1s, and folks who are nervous about side effects
We focus on the whole person, ensuring that your medication is just one part of a sustainable, medically supervised journey toward metabolic health
.jpg)
